LamisKEldjerouMD
Pediatric Hematology & Oncology • Gainesville, FLAssistant Professor, Pediatrics, University of Florida College of Medicine
Dr. Eldjerou is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1600 SW Archer Rd
Gainesville, FL 32610Phone+1 352-392-4479
Education & Training
New York Presbyterian Hospital (Cornell Campus)Fellowship, Pediatric Hematology/Oncology, 2006 - 2009
St Joseph's University Medical CenterResidency, Pediatrics, 2002 - 2005
Damascus University Faculty of MedicineClass of 1997
Certifications & Licensure
FL State Medical License 2009 - 2022
Clinical Trials
- Vincristine, Dexamethasone, Doxorubicin, and PEG-asparaginase (VPLD) and Metformin for Relapsed Childhood Acute Lymphoblastic Leukemia (ALL) Start of enrollment: 2011 Jul 18
- Metformin in Children With Relapsed or Refractory Solid Tumors Start of enrollment: 2012 Sep 24
- Sorafenib and Topotecan in Refractory/Recurrent Pediatric Malignancies Start of enrollment: 2013 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- 37 citationsPooled safety analysis of tisagenlecleucel in children and young adults with B cell acute lymphoblastic leukemia.John E. Levine, Stephan A. Grupp, Michael A. Pulsipher, Andrew C. Dietz, Susana Rives
Journal for Immunotherapy of Cancer. 2021-08-01 - 38 citationsGD2 chimeric antigen receptor modified T cells in synergy with sub-toxic level of doxorubicin targeting osteosarcomas.Monrat Chulanetra, Atthapan Morchang, Elias Sayour, Lamis Eldjerou, Rowan J. Milner
American Journal of Cancer Research. 2020-02-01 - 9 citationsIndustry's Giant Leap Into Cellular Therapy: Catalyzing Chimeric Antigen Receptor T Cell (CAR-T) Immunotherapy.Stacie Ittershagen, Solveig G. Ericson, Lamis K. Eldjerou, Ali Shojaee, Eric Bleickardt
Current Hematologic Malignancy Reports. 2019-02-01
Abstracts/Posters
- Correlative Analyses of Patient and Clinical Characteristics Associated with Efficacy in Tisagenlecleucel-Treated Relapsed/Refractory Diffuse Large B-Cell Lymphoma Pat...Lamis K. Eldjerou, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Economic Burden of Neurologic Toxicities Associated with Treating Relapsed Refractory Diffuse Large B-Cell Lymphoma in the United StatesLamis K. Eldjerou, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Correlation of Bridging and Lymphodepleting Chemotherapy with Clinical Outcomes in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma Treated with Tisagen...Lamis K. Eldjerou, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
